{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:36:07Z","timestamp":1761744967878,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001777","name":"University of Wollongong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001777","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001777","name":"University of Wollongong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001777","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.intimp.2019.04.037","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T12:29:54Z","timestamp":1556627394000},"page":"479-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The A2A receptor agonist CGS 21680 has beneficial and adverse effects on disease development in a humanised mouse model of graft-versus-host disease"],"prefix":"10.1016","volume":"72","author":[{"given":"N.J.","family":"Geraghty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.R.","family":"Adhikary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sluyter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2019.04.037_bb0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MOH.0000000000000026","article-title":"Graft-versus-host disease: why have we not made more progress?","volume":"21","author":"Jaglowski","year":"2014","journal-title":"Curr. Opin. Hematol."},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2019.04.037_bb0015","first-page":"21","article-title":"The biology of graft-versus-host reactions","volume":"62","author":"Billingham","year":"1965","journal-title":"Harvey Lect."},{"issue":"18","key":"10.1016\/j.intimp.2019.04.037_bb0020","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1182\/blood-2013-08-453126","article-title":"Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation","volume":"122","author":"Schneidawind","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.intimp.2019.04.037_bb0030","article-title":"A phylogenetic view of the leukocyte ectonucleotidases","author":"Ferrero","year":"2018","journal-title":"Immunol. Lett."},{"issue":"11","key":"10.1016\/j.intimp.2019.04.037_bb0035","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.humimm.2016.02.005","article-title":"The role of danger signals and ectonucleotidases in acute graft-versus-host disease","volume":"77","author":"Apostolova","year":"2016","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2019.04.037_bb0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11302-014-9427-2","article-title":"Purinergic signalling and immune cells","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal"},{"issue":"6","key":"10.1016\/j.intimp.2019.04.037_bb0045","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2019.04.037_bb0050","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/ajt.12567","article-title":"The purinergic system in allotransplantation","volume":"14","author":"Vergani","year":"2014","journal-title":"Am. J. Transplant."},{"issue":"19","key":"10.1016\/j.intimp.2019.04.037_bb0055","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1182\/blood-2011-09-375899","article-title":"Deficiency of CD73\/ecto-5\u2032-nucleotidase in mice enhances acute graft-versus-host disease","volume":"119","author":"Tsukamoto","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2019.04.037_bb0060","article-title":"Graft-versus-host disease is enhanced by selective CD73 blockade in mice","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.intimp.2019.04.037_bb0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1189\/jlb.0609388","article-title":"Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation","volume":"87","author":"Lappas","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0070","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4049\/jimmunol.1201325","article-title":"Adenosine A2A receptor agonist\u2013mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease","volume":"190","author":"Han","year":"2013","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2019.04.037_bb0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri2017","article-title":"Humanized mice in translational biomedical research","volume":"7","author":"Shultz","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2019.04.037_bb0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clim.2007.11.001","article-title":"A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene","volume":"126","author":"King","year":"2008","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2249.2009.03933.x","article-title":"Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex","volume":"157","author":"King","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2019.04.037_bb0090","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.bbmt.2018.04.016","article-title":"Comprehensive analysis of the activation and proliferation kinetics and effector functions of human lymphocytes, and antigen presentation capacity of antigen-presenting cells in xenogeneic graft-versus-host disease","volume":"24","author":"Kawasaki","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00005131","article-title":"Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells","volume":"357","author":"Klotz","year":"1998","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2019.04.037_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2019.02.003","article-title":"Increased splenic human CD4+:CD8+ T cell ratios, serum human interferon-\u03b3 and intestinal human interleukin-17 are associated with clinical graft-versus-host disease in humanized mice","author":"Geraghty","year":"2019","journal-title":"Transpl. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cei.13005","article-title":"The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-\u03b3 in a humanized mouse model of graft-versus-host disease","volume":"190","author":"Geraghty","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2019.04.037_bb0110","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.intimp.2019.04.037_bb0115","doi-asserted-by":"crossref","DOI":"10.1007\/s11302-017-9569-0","article-title":"The P2X7 receptor is not essential for development of imiquimod-induced psoriasis-like inflammation in mice","author":"Geraghty","year":"2017","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.intimp.2019.04.037_bb0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cellimm.2018.12.001","article-title":"Long-term treatment with the P2X7 receptor antagonist Brilliant Blue G reduces liver inflammation in a humanized mouse model of graft-versus-host disease","volume":"336","author":"Geraghty","year":"2019","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood-2005-06-2599","article-title":"Adenosine A2a receptors induce heterologous desensitization of chemokine receptors","volume":"108","author":"Zhang","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2019.04.037_bb0130","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s10753-011-9353-1","article-title":"The effect of A2A adenosine receptor activation on C-C chemokine receptor 7 expression in human THP1 macrophages during inflammation","volume":"35","author":"Williams","year":"2012","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.intimp.2019.04.037_bb0135","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.transproceed.2012.10.061","article-title":"Differences in the induction of induced human CD4+ CD25+ FoxP3+ T-regulatory cells and CD3+ CD8+ CD28\u2212 T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate\/ionomycin and phytohemagglutinin stimulation","volume":"45","author":"Wang","year":"2013","journal-title":"Transplant. Proc."},{"issue":"6","key":"10.1016\/j.intimp.2019.04.037_bb0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1083-8791(99)70011-X","article-title":"Pathophysiologic mechanisms of acute graft-vs.-host disease","volume":"5","author":"Ferrara","year":"1999","journal-title":"Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation"},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00504224","article-title":"Adenosine receptor activation by adenine nucleotides requires conversion of the nucleotides to adenosine","volume":"315","author":"Bruns","year":"1980","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2019.04.037_bb0150","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1172\/JCI11808","article-title":"Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function","volume":"107","author":"Kuroiwa","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clim.2014.11.004","article-title":"IL-10 exacerbates xenogeneic GVHD by inducing massive human T cell expansion","volume":"156","author":"Abraham","year":"2015","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2019.04.037_bb0160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1172\/JCI6896","article-title":"Differential roles of IL-1 and TNF-\u03b1 on graft-versus-host disease and graft versus leukemia","volume":"104","author":"Hill","year":"1999","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.intimp.2019.04.037_bb0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fimmu.2018.00010","article-title":"Simple, reproducible, and efficient clinical grading system for murine models of acute graft-versus-host disease","volume":"9","author":"Naserian","year":"2018","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2019.04.037_bb0170","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejphar.2011.06.049","article-title":"CGS 21680, an agonist of the adenosine (A2A) receptor, decreases acute lung inflammation","volume":"668","author":"Impellizzeri","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2019.04.037_bb0175","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11302-012-9299-2","article-title":"Anti-inflammatory effects of purine nucleosides, adenosine and inosine, in a mouse model of pleurisy: evidence for the role of adenosine A2 receptors","volume":"8","author":"da Rocha Lapa","year":"2012","journal-title":"Purinergic Signal"},{"issue":"10","key":"10.1016\/j.intimp.2019.04.037_bb0180","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3899\/jrheum.110111","article-title":"CGS 21680, an agonist of the adenosine (A2A) receptor, reduces progression of murine type II collagen-induced arthritis","volume":"38","author":"Mazzon","year":"2011","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2019.04.037_bb0185","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/bmt.2011.93","article-title":"Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD\/SCID\/\u03b3c- mouse model","volume":"47","author":"Gregoire-Gauthier","year":"2012","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.intimp.2019.04.037_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00276","article-title":"Combination of IL-10 and IL-2 induces oligoclonal human CD4 T cell expansion during xenogeneic and allogeneic GVHD in humanized mice","volume":"3","author":"Abraham","year":"2017","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.intimp.2019.04.037_bb0195","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1002\/eji.200939432","article-title":"Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD","volume":"39","author":"Koenecke","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/1078-0432.CCR-10-1198","article-title":"Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation","volume":"17","author":"Tawara","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2019.04.037_bb0205","first-page":"C530","article-title":"Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells","volume":"301","author":"Romio","year":"2011","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"9","key":"10.1016\/j.intimp.2019.04.037_bb0210","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+ CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2009.03.013","article-title":"Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD)","volume":"258","author":"Cao","year":"2009","journal-title":"Cell. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2019.04.037_bb0220","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2005-06-2529","article-title":"Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD","volume":"107","author":"Rieger","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.intimp.2019.04.037_bb0225","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.bbmt.2009.04.009","article-title":"Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response","volume":"15","author":"Fondi","year":"2009","journal-title":"Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation"},{"issue":"12","key":"10.1016\/j.intimp.2019.04.037_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051832","article-title":"Long-term engraftment of human natural T regulatory cells in NOD\/SCID IL2r\u03b3cnull mice by expression of human IL-2","volume":"7","author":"Abraham","year":"2012","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.intimp.2019.04.037_bb0235","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/cmi.2016.30","article-title":"Human CD39hi regulatory T cells present stronger stability and function under inflammatory conditions","volume":"14","author":"Gu","year":"2016","journal-title":"Cell. Mol. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2019.04.037_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005177","article-title":"CD39 expression identifies terminally exhausted CD8+ T cells","volume":"11","author":"Gupta","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2019.04.037_bb0245","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2019.04.037_bb0250","article-title":"Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression","author":"Brehm","year":"2018","journal-title":"FASEB J."},{"issue":"1943","key":"10.1016\/j.intimp.2019.04.037_bb0255","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3389\/fimmu.2018.01943","article-title":"Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2\/HHD mice","volume":"9","author":"Ehx","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2019.04.037_bb0260","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pbb.2008.01.006","article-title":"Systemic administration of the adenosine A2A agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake","volume":"89","author":"Mingote","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2019.04.037_bb0265","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/FBP.0b013e3283566a60","article-title":"A2A adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats","volume":"23","author":"Micioni Di Bonaventura","year":"2012","journal-title":"Behav. Pharmacol."},{"issue":"7531","key":"10.1016\/j.intimp.2019.04.037_bb0270","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature13816","article-title":"Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors","volume":"516","author":"Gnad","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2019.04.037_bb0275","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuropharm.2018.02.035","article-title":"Activation of adenosine A2A or A2B receptors causes hypothermia in mice","volume":"139","author":"Carlin","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.intimp.2019.04.037_bb0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm0102-75","article-title":"Interleukin-6-deficient mice develop mature-onset obesity","volume":"8","author":"Wallenius","year":"2002","journal-title":"Nat. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918312001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918312001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:17:49Z","timestamp":1761585469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918312001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":56,"alternative-id":["S1567576918312001"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.04.037","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The A2A receptor agonist CGS 21680 has beneficial and adverse effects on disease development in a humanised mouse model of graft-versus-host disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}